A Study of MG-K10 in Subjects With Atopic Dermatitis
Status:
Not yet recruiting
Trial end date:
2024-02-26
Target enrollment:
Participant gender:
Summary
This study evaluates the preliminary efficacy of MG-K10 in subjects with moderate to severe
asthma, and provides a basis for the design and dosing regimen of phase III clinical trials.